Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression

Am J Kidney Dis. 2005 Apr;45(4):788-9; author replyy 789-90. doi: 10.1053/j.ajkd.2005.01.033.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Chlorambucil / administration & dosage
  • Chlorambucil / therapeutic use*
  • Creatinine / blood
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Disease Progression
  • Drug Therapy, Combination
  • Glomerulonephritis, Membranous / complications
  • Glomerulonephritis, Membranous / drug therapy*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / prevention & control*
  • Proteinuria / etiology
  • Remission Induction
  • Risk Factors

Substances

  • Immunosuppressive Agents
  • Chlorambucil
  • Cyclophosphamide
  • Creatinine